Skip to main content
. Author manuscript; available in PMC: 2017 Feb 10.
Published in final edited form as: Int J Pharm. 2015 Nov 28;498(0):12–22. doi: 10.1016/j.ijpharm.2015.11.045

Figure 7.

Figure 7

B16-F0 melanoma tumors were implanted in C57-BL/6 mice. Once palpable tumors were formed, mice were treated with PL loaded SENE-3 or CNE-2 (n=8). (A) Average tumor volume measured by vernier calipers of control and PL treated mice. (B) Average weight of the tumors from control and PL loaded nanoemulsion treated mice taken when the experiment was terminated. * represents p<0.05 as compared to control.